These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20539077)

  • 1. The cost of treatment and care for people living with HIV infection: implications of published studies, 1999-2008.
    Beck EJ; Harling G; Gerbase S; DeLay P
    Curr Opin HIV AIDS; 2010 May; 5(3):215-24. PubMed ID: 20539077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equity and efficiency in scaling up access to HIV-related interventions in resource-limited settings.
    Cleary S
    Curr Opin HIV AIDS; 2010 May; 5(3):210-4. PubMed ID: 20539076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates of health care system costs of unsafe abortion in Africa and Latin America.
    Vlassoff M; Walker D; Shearer J; Newlands D; Singh S
    Int Perspect Sex Reprod Health; 2009 Sep; 35(3):114-21. PubMed ID: 19805016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia.
    Riyarto S; Hidayat B; Johns B; Probandari A; Mahendradhata Y; Utarini A; Trisnantoro L; Flessenkaemper S
    Health Policy Plan; 2010 Jul; 25(4):272-82. PubMed ID: 20156918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
    Beck EJ; Santas XM; Delay PR
    AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
    Gentilini M; Chieze F
    Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
    Beaulière A; Le Maux A; Trehin C; Perez F
    Rev Epidemiol Sante Publique; 2010 Jun; 58(3):171-9. PubMed ID: 20430553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to access to antiretroviral treatment in developing countries: a review.
    Posse M; Meheus F; van Asten H; van der Ven A; Baltussen R
    Trop Med Int Health; 2008 Jul; 13(7):904-13. PubMed ID: 18466183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
    Sante; 1999; 9(5):277-81. PubMed ID: 10657769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accounting for the cost of scaling-up health interventions.
    Johns B; Baltussen R
    Health Econ; 2004 Nov; 13(11):1117-24. PubMed ID: 15386683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
    Abramowitz S; Greene D
    AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB; Auld MC; Gill MJ;
    CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much will it cost? Estimation of resource needs and availability for HIV prevention, treatment and care for people who inject drugs in Asia.
    Bergenstrom A; McLeod R; Sharma M; Mesquita F; Dorabjee J; Atun R; Lewis G; Rao JV
    Int J Drug Policy; 2010 Mar; 21(2):107-9. PubMed ID: 20144859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011.
    Beck EJ; Fasawe O; Ongpin P; Ghys P; Avilla C; De Lay P
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):293-311. PubMed ID: 23763528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.